Baxter International Inc. (BAX) Stock

Valuation data is not available for this stock.

With a beta of 0.61, Baxter International Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.20 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Baxter International Inc. achieves a profit margin of -5.20%, meaning it retains $-5.20 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 9.75% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -3.51% and ROA at 2.50%, the company achieves moderate returns on invested capital.

Baxter International Inc.'s revenue grew by 5.40% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 237.90% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry averages for proper context.

Baxter International Inc. offers a dividend yield of 2.24%, paying $0.92 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment. To receive the next dividend, shares must be purchased before the ex-dividend date of 5/30/2025.

The dividend sustainability can be assessed through the payout ratio - Baxter International Inc. pays $0.92 per share in dividends against earnings of -$0.52 per share, resulting in a payout ratio of -176.92%. This conservative payout below 30% indicates excellent dividend safety with substantial room for future increases. The company retains most earnings for growth while still rewarding shareholders. The next dividend payment is scheduled for 7/1/2025.

Baxter International Inc. has a market capitalization of $15.60B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 513.17M shares outstanding, the company's ownership is relatively concentrated. As a participant in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, it competes with other firms in this sector.

Baxter International Inc.'s book value per share is $13.80, while the current stock price is $28.32, resulting in a price-to-book (P/B) ratio of 2.05. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

18 analysts cover BAX with 33% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $38.34 implies 35.4% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:2 Strong Buy, 4 Buy, 11 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

RSI data is not available for this stock.

MACD and moving average data are not available for this stock.